476 results match your criteria: "Centre d'Immunologie et des Maladies Infectieuses CIMI[Affiliation]"

CD4CD25Foxp3 regulatory T cells (Treg) have been implicated in pain modulation in various inflammatory conditions. However, whether Treg cells hamper pain at steady state and by which mechanism is still unclear. From a meta-analysis of the transcriptomes of murine Treg and conventional T cells (Tconv), we observe that the proenkephalin gene (), encoding the precursor of analgesic opioid peptides, ranks among the top 25 genes most enriched in Treg cells.

View Article and Find Full Text PDF

Background: Uterus transplantation (UTx) is an emerging therapy for women with uterine infertility. However, critical questions remain with this procedure including the mechanisms involved in graft rejection.

Methods: In this study, we analyzed the immune profile of ectocervical biopsies from 5 patients after UTx before and during their first episode of rejection using RNA sequencing, quantitative polymerase chain reaction, and imaging mass cytometry.

View Article and Find Full Text PDF

Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawal.

Joint Bone Spine

December 2024

Sorbonne Université, Inserm, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France; Sorbonne Université, centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte d'Ile-de-France, Centre et Martinique, Service de Médecine Interne 2, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, Institut E3M, Paris, France. Electronic address:

Objective: Previous studies have provided evidence that the discontinuation of hydroxychloroquine (HCQ), and chloroquine (CQ), in patients with systemic lupus erythematosus (SLE) is associated with an increased risk of disease flares, with limited information on the level of disease activity at the time of HCQ/CQ discontinuation. Here we aimed to describe the risk of SLE flare after withdrawal of HCQ or CQ in patients with SLE in remission.

Methods: Case-control study (1:2) comparing the evolution of patients with SLE after HCQ/CQ withdrawal for antimalarial retinopathy (cases) with patients with SLE matched for sex, antimalarial treatment duration and age at SLE diagnosis, whose antimalarial treatment was continued throughout the entire follow-up period (controls).

View Article and Find Full Text PDF

Extracellular vesicles such as exosomes are now recognized as key players in intercellular communication. Their role is influenced by the specific repertoires of proteins and lipids, which are enriched when they are generated as intraluminal vesicles (ILVs) in multivesicular endosomes. Here we report that a key component of small extracellular vesicles, the tetraspanin CD63, sorts cholesterol to ILVs, generating a pool that can be mobilized by the NPC1/2 complex, and exported via exosomes to recipient cells.

View Article and Find Full Text PDF

Clostridioides difficile (CD) infections are defined by toxins A (TcdA) and B (TcdB) along with the binary toxin (CDT). The emergence of the 'hypervirulent' (Hv) strain PR 027, along with PR 176 and 181, two decades ago, reshaped CD infection epidemiology in Europe. This study assessed MALDI-TOF mass spectrometry (MALDI-TOF MS) combined with machine learning (ML) and Deep Learning (DL) to identify toxigenic strains (producing TcdA, TcdB with or without CDT) and Hv strains.

View Article and Find Full Text PDF

[Hypersensitivity and mucocutaneous allergies in children and adults. Urticaria, atopic and contact dermatitis].

Rev Prat

April 2024

Service de dermatologie et allergologie, hôpital Tenon, Paris, France. Sorbonne université, UPMC université Paris-VI, unité mixte de recherche santé (UMR S) CR7, Centre d'immunologie et des maladies infectieuses (CIMI), Paris, Institut national de santé et de recherche médicale (Inserm) U1135, CIMI, Paris, France.

View Article and Find Full Text PDF

Objectives: Vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic (VEXAS) syndrome is an adult-onset autoinflammatory disease associated with somatic ubiquitin-like modifier-activating enzyme 1 (UBA1) mutations. We aimed to evaluate the efficacy and safety of targeted therapies.

Methods: Multicentre retrospective study including patients with genetically proven VEXAS syndrome who had received at least one targeted therapy.

View Article and Find Full Text PDF

COVID-19 is associated with heterogeneous outcome. Early identification of a severe progression of the disease is essential to properly manage the patients and improve their outcome. Biomarkers reflecting an increased inflammatory response, as well as individual features including advanced age, male gender, and pre-existing comorbidities, are risk factors of severe COVID-19.

View Article and Find Full Text PDF

New member of Plasmodium (Vinckeia) and Plasmodium cyclopsi discovered in bats in Sierra Leone - nuclear sequence and complete mitochondrial genome analyses.

Int J Parasitol

August 2024

Department of Molecular Parasitology, Institute of Biology, Humboldt University, Berlin, Germany; Department of Biological Sciences, Macquarie University, Sydney, Australia; Museum für Naturkunde, Leibniz-Institute for Evolution and Biodiversity Science, Berlin, Germany; Department of Biology, Muni University, Arua, Uganda. Electronic address:

Malaria remains the most important arthropod-borne infectious disease globally. The causative agent, Plasmodium, is a unicellular eukaryote that develops inside red blood cells. Identifying new Plasmodium parasite species that infect mammalian hosts can shed light on the complex evolution and diversity of malaria parasites.

View Article and Find Full Text PDF

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination.

JAMA Netw Open

April 2024

INSERM, U1111, CNRS, UMR 5308, CIRI-GIMAP, Université Claude Bernard Lyon 1, Université Jean Monnet, Immunology and Immunomonitoring Laboratory, iBiothera, CIC 1408, Saint-Étienne, France.

Importance: There is still considerable controversy in the literature regarding the capacity of intramuscular messenger RNA (mRNA) vaccination to induce a mucosal immune response.

Objective: To compare serum and salivary IgG and IgA levels among mRNA-vaccinated individuals with or without previous SARS-CoV-2 infection.

Design, Setting, And Participants: In this cohort study, SARS-CoV-2-naive participants and those with previous infection were consecutively included in the CoviCompare P and CoviCompare M mRNA vaccination trials and followed up to day 180 after vaccination with either the BNT162b2 (Pfizer-BioNTech) vaccine or the mRNA-1273 (Moderna) vaccine at the beginning of the COVID-19 vaccination campaign (from February 19 to June 8, 2021) in France.

View Article and Find Full Text PDF

Antiphospholipid Patients Admitted in the Intensive Care Unit: What Must The Rheumatologist Know?

Curr Rheumatol Rep

July 2024

Hôpital La Pitié-Salpêtrière, Service de Médecine Intensive-Réanimation, Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Purpose Of The Review: Antiphospholipid syndrome (APS) is a rare systemic autoimmune disorder that can escalate into a 'thrombotic storm' called the catastrophic antiphospholipid syndrome (CAPS), frequently requiring ICU admission for multiple organ failure. This review aims to offer insight and recent evidence on critically-ill APS patients.

Recent Findings: The CAPS classification criteria define this condition as the involvement of at least three organs/systems/tissues within less than a week, caused by small vessel thrombosis, in patients with elevated antiphospholipid antibodies levels.

View Article and Find Full Text PDF

Successful rescue TNF-α blocking for - Related immune reconstitution inflammatory syndrome: A case report.

Heliyon

April 2024

Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants-malades, Assistance publique-Hôpitaux de Paris, 149 rue de Sèvres, 75743, Paris, France.

Immune reconstitution inflammatory syndrome (IRIS) has been reported in immunocompromised patients with disseminated . Management relies on high-dose corticosteroids. We describe two cases of late-onset corticosteroid-refractory IRIS related to disseminated infection in a HIV-positive patient and a renal transplant patient who had a favorable outcome with a monoclonal TNF-α blocker.

View Article and Find Full Text PDF

Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade-a worldwide perspective.

EClinicalMedicine

April 2024

Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance Publique - Hôpitaux de Paris (AP-HP), Clinical Investigation Center (CIC-1901), Regional Pharmacovigilance Centre, Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France.

Article Synopsis
  • Immune-checkpoint inhibitors (ICI) have transformed cancer treatment by utilizing the immune system, but they can cause serious, life-threatening immune-related adverse events (irAE) that can affect various organs.
  • Analysis of data from the international pharmacovigilance database revealed 25 types of irAE across over 50,000 cases, with skin reactions and pneumonitis being the most common, and a shift in treatment regimens favoring anti-PD1 and anti-PDL1 therapies after 2016.
  • Specific risk factors for certain irAE include cancer types and treatment regimens, with a median onset time for complications varying greatly; this underscores the importance of monitoring during ICI therapy
View Article and Find Full Text PDF

[Advances in antibiotic therapy for tuberculosis].

Rev Prat

March 2024

AP-HP. Sorbonne Université, Centre national de référence des mycobactéries et de la résistance des mycobactéries aux antituberculeux, Paris, France. Sorbonne université, Inserm U1135, Centre d'immunologie et des maladies infectieuses (Cimi), Paris, France.

ADVANCES IN ANTIBIOTIC THERAPY FOR TUBERCULOSIS. Treatment of tuberculosis is experiencing significant advancements. For the first time, a therapeutic regimen based on rifapentine and moxifloxacin allows for a reduction of treatment duration of drug-susceptible tuberculosis from 6 to 4 months.

View Article and Find Full Text PDF

Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation.

J Exp Med

May 2024

CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308 , ENS de Lyon, Lyon, France.

Article Synopsis
  • NLRP3-associated autoinflammatory disease is a collection of genetic disorders caused by mutations that lead to increased activity of the NLRP3 protein, which complicates diagnosis despite effective treatments available.
  • The study explores 34 different NLRP3 mutations, illustrating their functional differences based on how they respond to various signals that activate them, and highlights their link to symptom severity and misdiagnosis.
  • Findings reveal critical areas in the NLRP3 protein that affect its activity and response to treatments, offering new perspectives on the disorder's variability and potential directions for improving diagnosis and therapy.
View Article and Find Full Text PDF

Invasive Aspergillosis with impaired neutrophil responses against Aspergillus fumigatus in patients treated with Acalabrutinib-findings from three cases.

Int J Infect Dis

May 2024

Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié, Salpêtrière, Service de Parasitologie-Mycologie, Paris, France.

Article Synopsis
  • Ibrutinib, a first-generation BTK inhibitor, increases the risk of invasive fungal infections, while the second-generation BTK inhibitor, acalabrutinib, has unknown effects on neutrophil antifungal activity despite only a few reported cases of aspergillosis during its use.
  • Three new cases of invasive aspergillosis were identified in patients with chronic lymphocytic leukemia shortly after starting acalabrutinib therapy, raising concern about its impact on immune response.
  • After one month of acalabrutinib treatment, neutrophils exhibited a reduced ability to fight against Aspergillus fumigatus, highlighting the need for close monitoring of patients on this medication for potential fungal infections.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the levels of HIV RNA and cytokines in adolescents who have been on antiretroviral treatment (ART) since early in life, focusing on potential indicators for clinical trials aimed at finding a cure for HIV.
  • It enrolled 40 perinatally infected adolescents on ART for over 5 years, measuring various HIV markers and correlating them with clinical characteristics.
  • Results show that lower levels of cell-associated RNA (CA-RNA) are linked to lower levels of cell-associated DNA (CA-DNA), and that undetectable CA-RNA is associated with factors like earlier initiation of ART and higher Western Blot scores.
View Article and Find Full Text PDF

[Towards sustainable science : research laboratories facing the climate emergency].

Med Sci (Paris)

February 2024

GreenLab, Centre d'immunologie et des maladies infectieuses (CIMI-Paris), Sorbonne-université, HôpitalPitié-Salpêtrière, Inserm U1135, CNRS ERL8255, Paris, France.

View Article and Find Full Text PDF

[The Nobel Prize in Physiology or Medicine 2023: Katalin Karikó and Drew Weissman - A vaccine revolution driven by fundamental research in immunology and molecular biology].

Med Sci (Paris)

February 2024

Laboratoire « Microenvironnement immunitaire et immunothérapie », Centre d'immunologie et des maladies infectieuses (CIMI), Inserm U1135, Faculté de Santé, Sorbonne université, Paris, France.

View Article and Find Full Text PDF

Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patients.

Semin Arthritis Rheum

June 2024

Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP), Groupe Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France. Electronic address:

Background: Long-term hydroxychloroquine (HCQ) or chloroquine (CQ) intake causes retinal toxicity in 0.3-8 % of patients with rheumatic diseases. Numerous risk factors have been described, eg, daily dose by weight, treatment duration, chronic kidney disease, concurrent tamoxifen therapy and pre-existing retinal or macular disease.

View Article and Find Full Text PDF

Systemic lupus erythematosus associated with HIV infection: a retrospective case-control study.

Clin Exp Rheumatol

July 2024

Assistance Publique - Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, Centre National de Référence pour le Lupus, le Syndrome des Anticorps Anti-phospholipides et Autres Maladies Auto-immunes Rares, Service de Médecine Interne 2, Institut E3M; and Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

Article Synopsis
  • The study investigates the characteristics of systemic lupus erythematosus (SLE) in patients also living with human immunodeficiency virus (HIV) and compares these characteristics to those in SLE patients without HIV.
  • Researchers analyzed data from 13 SLE patients with HIV, noting a median diagnosis age of 43, with 77% being women, and identifying common symptoms such as joint pain and skin issues.
  • The findings reveal that SLE patients with HIV exhibit more kidney problems and autoimmune blood issues compared to those without HIV, highlighting a rare but significant relationship between these conditions.
View Article and Find Full Text PDF